Clinical Trial Update: Safety of Injection of Placental Mesenchymal Stem Cell Derived Exosomes for Treatment of Resistant Perianal Fistula in Crohn's Patients [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update reports safety data for injection of placental mesenchymal stem cell–derived exosomes in Crohn's-associated perianal fistula, spanning P…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Perianal Fistula

Drugs mentioned

• placental mesenchymal stem cell–derived exosomes

Snippet

Sponsor: Tehran University of Medical Sciences | Conditions: Perianal Fistula in Patients With Crohn's Disease | Phase 1, Phase 2 | Status: UNKNOWN